2,172
Views
25
CrossRef citations to date
0
Altmetric
Research Article

A novel redox/pH dual-responsive and hyaluronic acid-decorated multifunctional magnetic complex micelle for targeted gambogic acid delivery for the treatment of triple negative breast cancer

, , , , , , , , , & show all
Pages 1846-1857 | Received 26 Apr 2018, Accepted 05 Jun 2018, Published online: 18 Oct 2018

References

  • Auterhoff H, Frauendorf H, Liesenklas W, Schwandt C. (1962). The chief constituents of gamboge resins. 1. Chemistry of gamboge. Archiv Der Pharmazie 295:833–46.
  • Bauhuber S, Hozsa C, Breunig M, G Pferich A. (2009). Delivery of nucleic acids via disulfide-based carrier systems. Adv Mater 21:3286–306.
  • Brewster AM, Chavez-Macgregor M, Brown P. (2014). Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry. Lancet Oncol 15:e625–34.
  • Carey LA, Dees EC, Sawyer L, et al. (2007). The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 13:2329–34.
  • Chen HP, Chen MH, Tung FI, Liu TY. (2015). A novel micelle-forming material used for preparing a theranostic vehicle exhibiting enhanced in vivo therapeutic efficacy. J Med Chem 58:3704–19.
  • Cheng D, Hong G, Wang W, et al. (2011). Nonclustered magnetite nanoparticle encapsulated biodegradable polymeric micelles with enhanced properties for in vivo tumor imaging. J Mater Chem 21:4796–804.
  • Coley HM. (2008). Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer. Cancer Treat Rev 34:378.
  • Daly WH, Poch D. (1988). The preparation of N-carboxyanhydrides of α-amino acids using bis(trichloromethyl)carbonate. Tetrahedron Lett 29:5859–62.
  • Dey A, Koli U, Dandekar P, Jain R. (2016). Investigating behaviour of polymers in nanoparticles of chitosan oligosaccharides coated with hyaluronic acid. Polymer 93:44–52.
  • Doddapaneni R, Patel K, Owaid IH, Singh M. (2016). Tumor neo-vasculature targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple negative breast cancer. Drug Deliv 23:1232–10.
  • Gelmon K, Dent R, Mackey JR, et al. (2012). Targeting triple-negative breast cancer: optimising therapeutic outcomes. Ann Oncol 23:2223.
  • Gu H, Rao S, Zhao J, et al. (2009). Gambogic acid reduced bcl-2 expression via p53 in human breast MCF-7 cancer cells. J Cancer Res Clin Oncol 135:1777–82.
  • Guo X, Shi C, Yang G, et al. (2014). Dual-Responsive Polymer Micelles for Target-Cell-Specific Anticancer Drug Delivery. Chem Mater 26:4405–18.
  • Guo X, Wei X, Jing Y, Zhou S. (2015). Size changeable nanocarriers with nuclear targeting for effectively overcoming multidrug resistance in cancer therapy. Adv Mater 27:6450–6.
  • Hauser AK, Mitov MI, Daley EF, et al. (2016). Targeted iron oxide nanoparticles for the enhancement of radiation therapy. Biomaterials 105:127–35.
  • Hu YW, Du YZ, Liu N, et al. (2015). Selective redox-responsive drug release in tumor cells mediated by chitosan based glycolipid-like nanocarrier. J Control Release 206:91–100.
  • Huang R, Li J, Kebebe D, et al. (2018). Cell penetrating peptides functionalized gambogic acid-nanostructured lipid carrier for cancer treatment. Drug Deliv 25:757.
  • Kang Y, Lu L, Lan J, et al. (2017). Redox-responsive polymeric micelles formed by conjugating gambogic acid with bioreducible poly(amido amine)s for the co-delivery of docetaxel and MMP-9 shRNA. Acta Biomaterialia 68:137–153.
  • Kim DH, Kline DG, Hudson AR. (2008). Kline and Hudson's nerve injuries: operative results for major nerve injuries, entrapments and tumors. Elsevier Saunders.
  • Lee J, Isobe T, Senna M. (1996). Preparation of Ultrafine Fe3O4 Particles by Precipitation in the Presence of PVA at High pH. J Colloid Interface Sci 177:490–4.
  • Liu L, Yi H, He H, et al. (2017). Tumor associated macrophage-targeted microRNA delivery with dual-responsive polypeptide nanovectors for anti-cancer therapy. Biomaterials 134:166.
  • Liu L, Yi H, Wang C, et al. (2016). Integrated nanovaccine with microRNA-148a inhibition reprograms tumor-associated dendritic cells by modulating miR-148a/DNMT1/SOCS1 axis. Ji 197:1231.
  • Luo Z, Wang C, Yi H, et al. (2015). Nanovaccine loaded with poly I:C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo. Biomaterials 38:50–60.
  • Palmer JR, Viscidi E, Troester MA, et al. (2014). Parity, lactation, and breast cancer subtypes in African American Women: results from the AMBER Consortium. J Natl Cancer Inst 106:10.
  • Price C, Chen J. (2014). MicroRNAs in cancer biology and therapy: current status and perspectives. Genes Dis 1:53–63.
  • Qi Q, Lu N, Wang XT, et al. (2008). Anti-invasive effect of gambogic acid in MDA-MB-231 human breast carcinoma cells. Biochem Cell Biol 86:386.
  • Rekha MR, Sharma CP. (2015). Simultaneous effect of thiolation and carboxylation of chitosan particles towards mucoadhesive oral insulin delivery applications: an in vitro and in vivo evaluation. J Biomed Nanotechnol 11:165–76.
  • Sang M, Zhang Z, Liu F, et al. (2018). Multifunctional hyaluronic acid-decorated redox-responsive magnetic complex micelle for targeted drug delivery with enhanced antitumor efficiency and anti-cell-migration activity. J Biomed Nanotechnol 14:477–95.
  • Sata F, Suzuki K, Toh M, et al. (2007). Maternal serum folate levels, smoking, and alcohol habits during pregnancy and infant size at birth. Epidemiology 18:S56–7.
  • Sharma KK, Al E. (2006). Development and evaluation of transgenic groundnut expressing the rice chitinase gene for resistance to Aspergillus flavus. Groundnut.
  • Song S, Chen F, Qi H, et al. (2014). Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel. Pharm Res 31:1032.
  • Turner NC, Reis-Filho JS. (2013). Tackling the diversity of triple-negative breast cancer. Clin Cancer Res 19:6380–8.
  • Wang J, Wang F, Li F, et al. (2016). A multifunctional poly(curcumin) nanomedicine for dual-modal targeted delivery, intracellular responsive release, dual-drug treatment and imaging of multidrug resistant cancer cells. J Mater Chem B 4:2954.
  • Wang S, Shao M, Zhong Z, et al. (2017a). Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer. Drug Deliv 24:1791–800.
  • Wang X, Deng R, Lu Y, et al. (2013). Gambogic acid as a non-competitive inhibitor of ATP-binding cassette transporter B1 reverses the multidrug resistance of human epithelial cancers by promoting ATP-binding cassette transporter B1 protein degradation. Basic Clin Pharmacol Toxicol 112:25–33.
  • Wang Y, Wei G, Zhang X, et al. (2017b). Multistage targeting strategy using magnetic composite nanoparticles for synergism of photothermal therapy and chemotherapy. Small 14:e1702994.
  • Wang Y, Wei G, Zhang X, et al. (2017c). A Step-by-step multiple stimuli-responsive nanoplatform for enhancing combined chemo-photodynamic therapy. Adv Mater 24:1791–1800.
  • Yang Y, Yang L, You QD, et al. (2007). Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes. Cancer Lett 256:259.
  • Yi H, Liu P, Sheng N, et al. (2016). In situ crosslinked smart polypeptide nanoparticles for multistage responsive tumor-targeted drug delivery. Nanoscale 8:5985.
  • Zheng C, Zheng M, Gong P, et al. (2013). Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy. Biomaterials 34:3431–8.